This report presents broad estimates of the costs of delivering COVID-19 vaccines to approximately 20% of the population in the 92 Advance Market Commitment (AMC) countries. It is assumed that the existing health system will be leveraged, and only additional resources are included - defined as financial costs. Importantly, the costs of health worker salaries are excluded from the estimates.

Total financial costs - including country, regional, and global level costs - amount to US$ 2.018 billion, equivalent to US$ 1.66 per dose supplied and US$ 3.70 per person vaccinated with two doses (after accounting for vaccine wastage).

Technical assistance and global and regional costs amount to 15% of total costs. In-country outreach and fixed site delivery comprises 57% of total costs. In-country, up-front costs, such as cold chain installation and training, comprise 28% of the total.